Skip to main content

Dermatomyositis clinical trials at UCSF

3 in progress, 1 open to eligible people

Dermatomyositis is a disorder that leads to muscle weakness and skin rashes. UCSF is exploring the effects of a treatment called efgartigimod on adults with this condition. The trial focuses on evaluating the safety and effectiveness of the treatment for muscle inflammation.

Showing trials for

Our lead scientists for Dermatomyositis research studies include .

Last updated: